Brief: Cue Biopharma Reports Second Quarter 2022 Financial Results
04/08/2022 22:26
Aug 4 (Reuters) - Cue Biopharma Inc CUE.O :
* CUE BIOPHARMA REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
* CUE BIOPHARMA INC - QTRLY NET LOSS PER COMMON SHARE -
BASIC AND
DILUTED $0.37
Source text for Eikon: ID:nGNX9Rwzx1
Further company coverage: CUE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cue Biopharma
See all newsU.S. STOCKS ON THE MOVE-Insmed, Marvell, Meta
US STOCKS ON THE MOVE-Meta, Marvell Technology, Insmed
U.S. STOCKS ON THE MOVE-Accenture, Arhaus, Alkermes
Cue Biopharma surges after positive results from mid-stage study for CUE-221
Brief: Cue Biopharma Announces Positive Topline Results From Cue-221 Phase 2 Study In Chronic Spontaneous Urticaria